Analysts Offer Predictions for CNTX Q1 Earnings
Context Therapeutics Inc. (NASDAQ:CNTX – Free Report) – Investment analysts at William Blair issued their Q1 2025 EPS estimates for Context Therapeutics in a report issued on Monday, April 21st. William Blair analyst M. Phipps forecasts that the company will post earnings per share of ($0.05) for the quarter. William Blair currently has a “Outperform” […]
